<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药明康德 | wechat-feeds</title><link>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</link><description>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 08 Mar 2021 16:44:34 +0800</pubDate><image><url>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</url><title>药明康德 | wechat-feeds</title><link>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>半路改行还能拿诺奖，乳腺癌都拦不住她的硬核人生</title><link>https://mp.weixin.qq.com/s/B5JD69prIX3zy-YSF1HCmw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPPMNAdD8zuOaOmNHpbU6iaWzkib6fCH4wT3FL62h36GYKia7huNA0spkoJUbicaHiaGrKFP9JU15FQkJA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>把握书写人生的画笔]]></content:encoded><pubDate>Mon, 08 Mar 2021 07:01:54 +0800</pubDate></item><item><title>辉瑞、诺华、礼来等纷纷看好，它能否成为药物开发的下一个风口？|奕拓医药CEO独家点评</title><link>https://mp.weixin.qq.com/s/WGQbTDVOUA5deqBTEQROoA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/IeJiaQ7ImT1w72bYCg4TXuqW8OWuib5xtgDlftjHx8tVuyxhMhd2icEDJQhWLnyMd8NAP4DKQA63QIUlgoptzQkOA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>特别邀请奕拓医药CEO朱继东博士做独家点评！]]></content:encoded><pubDate>Mon, 08 Mar 2021 07:01:54 +0800</pubDate></item><item><title>速递 | 74%患者持续缓解超过18个月，吉利德CAR-T疗法斩获第三项适应症</title><link>https://mp.weixin.qq.com/s/9wCOSF2Co-YKWpgAvgr7Kw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPPMNAdD8zuOaOmNHpbU6iaW9eiaY8CyBMElVC659vDCTTgR25vGwiaRGth0WRn80TsIkG3ia3SfPrrvw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>第一款获批治疗惰性滤泡性淋巴瘤患者的CAR-T细胞疗法。]]></content:encoded><pubDate>Mon, 08 Mar 2021 07:01:54 +0800</pubDate></item><item><title>孤儿药周报 | 寡核苷酸药物、“即用型”T淋巴细胞疗法等11款疗法入围</title><link>https://mp.weixin.qq.com/s/KuUTM7UxhA9GAkZ4idVk0Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPPMNAdD8zuOaOmNHpbU6iaW80OJ0iaibCBFc5Mf4BLvBZ8OchfMIialOicINT32ARs6crribLNWMYdMQicA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Mon, 08 Mar 2021 07:01:54 +0800</pubDate></item><item><title>​“first-in-class”肽偶联药物获FDA加速批准；礼来糖尿病创新疗法达到3期临床终点</title><link>https://mp.weixin.qq.com/s/8AMIWV_fmsI_3ZTrDaKbGQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gMC7Jkicu62OkQRKGnIuzoljQw48c5grMFnFyu5d81ac1qKdwzsGTvXTJxia2ibRAgjlq9kjB9ibvBadQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>一周行业新闻回顾]]></content:encoded><pubDate>Mon, 08 Mar 2021 07:01:54 +0800</pubDate></item><item><title>明日下午3点！新药研发的新引擎，基于CRISPR文库的靶标体外及体内筛选</title><link>https://mp.weixin.qq.com/s/S7ypb6Jf2rS_Ov2lVdcq1g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gPPMNAdD8zuOaOmNHpbU6iaWfohvgQwJqficxQKGP1wRblK9miae1K6vpTu37AiaY6lK2fTPEJWQNgZ4A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>肿瘤免疫系列（七）]]></content:encoded><pubDate>Mon, 08 Mar 2021 07:01:54 +0800</pubDate></item><item><title>治疗癌症，蛋白降解疗法面临哪些挑战和机遇？</title><link>https://mp.weixin.qq.com/s/XH_Wc3ra3yvQp8Ri_4CQFQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNM3ws0HCG588vGTu9rlFWvzam72uVWF5fCJj53MCK3wQibaNVRHmT0bib0kKT7wvjel801W4UAjdvw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>在肿瘤学领域，靶向蛋白降解疗法开发正处在一个令人兴奋的转折点]]></content:encoded><pubDate>Sat, 06 Mar 2021 08:03:57 +0800</pubDate></item><item><title>2021年以来，高瓴创投已投资的12家中国生物医药公司，它们有何亮点？</title><link>https://mp.weixin.qq.com/s/PV5BkGIS5leVpQrCuTLQmg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/IeJiaQ7ImT1x7icIzZvZKniaaZuic4gOw1ezQibBh9fpq3e3PysLm2HYXC3cQ2uIZs9SOjktVuBNib4RvqIDXDD3mK9A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>三叶草生物、爱科百发、嘉因生物]]></content:encoded><pubDate>Sat, 06 Mar 2021 08:03:57 +0800</pubDate></item><item><title>速递 | 首款生物制品疗法，基因泰克IL-6受体抑制剂获批治疗罕见肺病</title><link>https://mp.weixin.qq.com/s/mSE9rzabONzDB4IQY54_2Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNM3ws0HCG588vGTu9rlFWvUnwNG9YAvbBTB0y3C3wibGVItQ6VQIxricYBv5ammlWZqtMElvJJ0MUw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>延缓肺功能衰退]]></content:encoded><pubDate>Sat, 06 Mar 2021 08:03:57 +0800</pubDate></item><item><title>速递 | 帮助手术医生“照亮”肿瘤，创新疗法获FDA优先审评资格</title><link>https://mp.weixin.qq.com/s/FdRGW2CylNVXU3LcFwe7qg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNM3ws0HCG588vGTu9rlFWvzia5MsjEsmicRk0PdASf0FF3yC4bEQjhMzncf6pxU3O9wEtibxBtLsjTA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>在48%的患者中发现额外病灶]]></content:encoded><pubDate>Sat, 06 Mar 2021 08:03:57 +0800</pubDate></item><item><title>唱，跳，rap……别笑，这群博士在解释他们的研究呢！（附视频）</title><link>https://mp.weixin.qq.com/s/EX0XDRV3l7cjSIOQouh5VA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/UdvecgtVRYLbQicpdNucugsRxHice8IaTG9O5CUBCCPdQQ8MV6cUHCmjicxBb4SL4P6zCjN7MIjD8bHu7CQSaLZfw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>跳出你的Ph.D.”大赛获奖作品]]></content:encoded><pubDate>Sat, 06 Mar 2021 08:03:57 +0800</pubDate></item><item><title>​中国45%的癌症死亡可预防，做好这几点很重要！国家癌症中心分析近30年数据</title><link>https://mp.weixin.qq.com/s/q2pJQcToLuMgM0OFH-_ZqQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/xlFoDVCgSYHtGBoW1uUhHQwm1xszdCCkjBibvvm0FicOKXNp6TkHF4wt65Es5JjicN5GPseTdneBYFyFyP5cibibpfw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2020年约导致300万人死亡]]></content:encoded><pubDate>Sat, 06 Mar 2021 08:03:57 +0800</pubDate></item><item><title>安进近20亿美元囊获创新胃癌一线疗法，再鼎拥有大中华区权益</title><link>https://mp.weixin.qq.com/s/Dqzq7MfyjwwEQgTPSxwUkw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOprj5Jh59eibBDeNkiawRdhhpPNqEAfibkYXrsK7DXZXNicA70MMcbzib2vYA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>治疗胃癌的精准疗法]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>速递 | 一线治疗非小细胞肺癌，辉瑞第三代ALK抑制剂获FDA批准</title><link>https://mp.weixin.qq.com/s/07lvvknKCa2mUSrNN3ngJw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpaxTibbYhlhDvSkH0bOL4FFrq0KPibmnrcTRThr9UIklMC7uTPTr4ygww/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>降低疾病进展和死亡风险72%]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>速递 | 50%患者血糖指标达到正常水平，礼来糖尿病创新疗法达到3期临床终点</title><link>https://mp.weixin.qq.com/s/N-z2brmzWwUxMxzqZBM6vw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpibWua4DtVZrHGCkibibiaSHX9F55qYH8WH3Ro6qVvTMJH1B8IzgjWYdP8w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>GIP/GLP-1受体双重激动剂]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>连发3篇顶刊！《柳叶刀》：索马鲁肽带来2型糖尿病体重管理突破，全面改善健康</title><link>https://mp.weixin.qq.com/s/gjRyor1Np-9YKYUuiej-BA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpIt4ZTCy2ypAHxhs5ibaeI10R5GWEHY7FetRDmeZsuPqV9KOLzibG4cOQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>超过1/4的患者减重超过15%]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>ASCO权威发布！2020年抗癌领域20项重要临床研究，它们有哪些亮点？</title><link>https://mp.weixin.qq.com/s/SdsDa5a4F3sKcrfk6gzkoA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpmCqHOiaDVN8fndNWSFN7zgFHcKbo7Iolgl3y5kKpic4TBPeVdK6YHCLQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>ASCO年度抗癌进展报告]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>一个家庭三场癌症…他痛失独子，却给千万患者带来了希望</title><link>https://mp.weixin.qq.com/s/x06SGR_V4eLmf1Ev9Mj0Gg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gOojLqRibsalhbyiaibdtQjQqyOrzwUHeQW5IhWEynVusJknpCPCDar9OtTiaO3jGpB82IgObj52VRcicg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>开发突破性技术，提高人们生存机会]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:17:26 +0800</pubDate></item><item><title>成功促进头发再生！礼来JAK抑制剂达到3期临床终点</title><link>https://mp.weixin.qq.com/s/oM0Ee9F8bnqep-W6SlIB3g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gOojLqRibsalhbyiaibdtQjQqyG9YVpIk55OvP2MUBK8qKgiapvqBvxSekxMh1G8PkNgp8MenYDt55GQg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>首个在治疗斑秃的3期临床试验中获得积极结果的JAK抑制剂]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:17:26 +0800</pubDate></item><item><title>速递 | 使用两周，管用3年？糖尿病免疫疗法公布最新结果</title><link>https://mp.weixin.qq.com/s/h2LttPtdmeS2fCXhxJKcXA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpBygEdZh4yacw1OKtBfed77VW3axn5VWCjVyCwq74aTY4BO3kDKDPwA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>今年夏天有望获得FDA批准]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:17:26 +0800</pubDate></item></channel></rss>